Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection
Pharmacology, Toxicology and Pharmaceutical Science
20
4%
Other
58
11%
Unknown
181
36%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 151. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2026.
All research outputs
#345,285
of 34,492,055 outputs
Outputs from Clinical Infectious Diseases
#650
of 21,572 outputs
Outputs of similar age
#1,046
of 161,906 outputs
Outputs of similar age from Clinical Infectious Diseases
#2
of 115 outputs
Altmetric has tracked 34,492,055 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,572 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,906 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.
